...
首页> 外文期刊>Frontiers in Microbiology >Optimization and Characterization of a Galleria mellonella Larval Infection Model for Virulence Studies and the Evaluation of Therapeutics Against Streptococcus pneumoniae
【24h】

Optimization and Characterization of a Galleria mellonella Larval Infection Model for Virulence Studies and the Evaluation of Therapeutics Against Streptococcus pneumoniae

机译:用于研究毒力的幼虫感染模型的优化,表征以及对肺炎链球菌治疗效果的评价

获取原文
           

摘要

Streptococcus pneumoniae is the leading cause of bacterial pneumonia. Infection is linked to high morbidity and mortality rates and antibiotic resistance within this pathogen is on the rise. Therefore, there is a need for novel antimicrobial therapies. To lower the time and costs of the drug discovery process, alternative in vivo models should be considered. As such, Galleria mellonella larvae can be of great value. The larval immunity consisting of several types of haemocytes is remarkably similar to the human innate immune system. Furthermore, these larvae don’t require specific housing, are cheap and are easy to handle. In this study, the use of a G. mellonella infection model to study early pneumococcal infections and treatment is proposed. Firstly, the fitness of this model to study pneumococcal virulence factors is confirmed using streptococcal strains TIGR4, ATCC ~(?)49619, D39 and its capsule-deficient counterpart R6 at different inoculum sizes. The streptococcal polysaccharide capsule is considered the most important virulence factor without which streptococci are unable to sustain an in vivo infection. Kaplan–Meier survival curves showed indeed a higher larval survival after infection with streptococcal strain R6 compared to strain D39. Then, the infection was characterized by determining the number of haemocytes, production of oxygen free radicals and bacterial burden at several time points during the course of infection. Lastly, treatment of infected larvae with the standard antibiotics amoxicillin and moxifloxacin was evaluated. Treatment has proven to have a positive outcome on the course of infection, depending on the administered dosage. These data imply that G. mellonella larvae can be used to evaluate antimicrobial therapies against S. pneumoniae , apart from using the larval model to study streptococcal properties. The in-depth knowledge acquired regarding this model, makes it more suitable for use in future research.
机译:肺炎链球菌是细菌性肺炎的主要原因。感染与高发病率和高死亡率有关,这种病原体中的抗生素耐药性正在上升。因此,需要新颖的抗微生物疗法。为了减少药物发现过程的时间和成本,应考虑使用其他体内模型。因此,梅花圆顶幼虫具有很大的价值。由几种类型的血细胞组成的幼虫免疫力与人类先天免疫系统非常相似。此外,这些幼虫不需要特殊的外壳,价格便宜并且易于处理。在这项研究中,提出了利用G. mellonella感染模型研究早期肺炎球菌感染和治疗的方法。首先,使用链球菌菌株TIGR4,ATCC〜(?)49619,D39及其胶囊缺陷对应物R6在不同接种量下,证实该模型适合研究肺炎球菌毒力因子。链球菌多糖胶囊被认为是最重要的毒力因子,没有链球菌就无法维持体内感染。 Kaplan–Meier生存曲线确实显示,与D39株相比,链球菌R6株感染后幼虫的存活率更高。然后,通过确定感染过程中几个时间点的血细胞数量,氧自由基的产生和细菌负荷来表征感染。最后,评估了用标准抗生素阿莫西林和莫西沙星治疗感染的幼虫。事实证明,根据给药剂量,治疗在感染过程中会产生积极的结果。这些数据表明,除使用幼虫模型研究链球菌特性外,G。mellonella幼虫还可用于评估针对肺炎链球菌的抗菌疗法。关于此模型的深入知识使其更适合将来的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号